微信公众号:蹊之美股生物医药 / CaesarBiotech
Gainers:
NeuroMetrix (NASDAQ:NURO) +65%
Reneo Pharmaceuticals (NASDAQ:RPHM) +25%
Neoleukin Therapeutics (NASDAQ:NLTX) +23%
InspireMD (NASDAQ:NSPR) +16%
Chembio Diagnostics (N...查看全文
$InspireMD Inc.(NSPR)$ 424B5 - Prospectus [Rule 424(b)(5)] Filed: 2018-03-28 AccNo: 0001615774-18-002126 Size: 598 KB 网页链接
$InspireMD Inc.(NSPR)$ 8-K - Current report Filed: 2018-03-27 AccNo: 0001615774-18-002114 Size: 39 KBItem 8.01: Other EventsItem 9.01: Financial Statements and Exhibits 网页链接
$InspireMD Inc.(NSPR)$ 8-K - Current report Filed: 2018-03-27 AccNo: 0001615774-18-002114 Size: 39 KBItem 8.01: Other EventsItem 9.01: Financial Statements and Exhibits 网页链接
$InspireMD Inc.(NSPR)$ EFFECT - Notice of Effectiveness Filed: 2018-03-14 AccNo: 9999999995-18-000602 Size: 1 KB 网页链接
$InspireMD Inc.(NSPR)$ 424B3 - Prospectus [Rule 424(b)(3)] Filed: 2018-03-14 AccNo: 0001493152-18-003344 Size: 198 KB 网页链接
$InspireMD Inc.(NSPR)$ S-3 - Registration statement under Securities Act of 1933 Filed: 2018-03-08 AccNo: 0001493152-18-003105 Size: 392 KB 网页链接
$InspireMD Inc.(NSPR)$ 8-K - Current report Filed: 2018-03-05 AccNo: 0001493152-18-002883 Size: 48 KBItem 8.01: Other EventsItem 9.01: Financial Statements and Exhibits 网页链接
$InspireMD Inc.(NSPR)$ 8-K - Current report Filed: 2018-03-01 AccNo: 0001493152-18-002799 Size: 213 KBItem 1.01: Entry into a Material Definitive AgreementItem 3.03: Material Modifications to Rights of Security HoldersItem 5.03: Amendments to Articles of Incorporation or Byla...
$InspireMD Inc.(NSPR)$ 8-K - Current report Filed: 2018-02-28 AccNo: 0001493152-18-002726 Size: 408 KBItem 1.01: Entry into a Material Definitive AgreementItem 3.02: Unregistered Sales of Equity SecuritiesItem 8.01: Other EventsItem 9.01: Financial Statements and Exhibits htt...
$InspireMD Inc.(NSPR)$ 424B5 - Prospectus [Rule 424(b)(5)] Filed: 2018-02-28 AccNo: 0001493152-18-002723 Size: 744 KB 网页链接